Fawaz E. Alanazi, Homood M. As Sobeai, Khalid Alhazzani, Abdullah Al-Dhfyan, Musaad A Alshammari, Moureq Alotaibi, . . . Ali Alhoshani. (2022). Metformin attenuates V-domain Ig suppressor of T-cell activation through the aryl hydrocarbon receptor pathway in Melanoma: In Vivo and In Vitro Studies. Elsevier.
Chicago Style (17th ed.) CitationFawaz E. Alanazi, Homood M. As Sobeai, Khalid Alhazzani, Abdullah Al-Dhfyan, Musaad A Alshammari, Moureq Alotaibi, Khaled Al-hosaini, Hesham M. Korashy, and Ali Alhoshani. Metformin Attenuates V-domain Ig Suppressor of T-cell Activation Through the Aryl Hydrocarbon Receptor Pathway in Melanoma: In Vivo and In Vitro Studies. Elsevier, 2022.
MLA (9th ed.) CitationFawaz E. Alanazi, et al. Metformin Attenuates V-domain Ig Suppressor of T-cell Activation Through the Aryl Hydrocarbon Receptor Pathway in Melanoma: In Vivo and In Vitro Studies. Elsevier, 2022.